Advanced search
Publication Cover
International Journal of Hyperthermia Volume 34, 2018 - Issue 5
Submit an article Journal homepage
1,066
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Comparative efficacy evaluation of catheter intraperitoneal chemotherapy, normothermic and hyperthermic chemoperfusion in a rat model of ascitic ovarian cancer

Vladimir G. BespalovScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; ;International Research Centre “Biotechnologies of the Third Millennium”, ITMO University, St. Petersburg, Russia; Correspondence[email protected]
View further author information
,
Ivan K. AlvovskyScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; ;International Research Centre “Biotechnologies of the Third Millennium”, ITMO University, St. Petersburg, Russia; View further author information
,
Grigory V. TochilnikovScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; ;International Research Centre “Biotechnologies of the Third Millennium”, ITMO University, St. Petersburg, Russia; View further author information
,
Alexandr N. StukovScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; View further author information
,
Ekaterina A. VyshinskayaScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; View further author information
,
Alexandr L. SemenovScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; ;International Research Centre “Biotechnologies of the Third Millennium”, ITMO University, St. Petersburg, Russia; View further author information
,
Irina N. VasilyevaScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; ;International Research Centre “Biotechnologies of the Third Millennium”, ITMO University, St. Petersburg, Russia; View further author information
,
Olesya A. BelyaevaScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; View further author information
,
Galina S. KireevaScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; View further author information
,
Konstantin Y. SenchikScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; View further author information
,
Nadezhda T. ZhilinskayaScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; View further author information
,
Julia D. VonScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; View further author information
,
Larisa A. KrasilnikovaScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; View further author information
,
Valery A. AlexandrovScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; ;International Research Centre “Biotechnologies of the Third Millennium”, ITMO University, St. Petersburg, Russia; View further author information
,
Nikita N. Khromov-BorisovScientific Council, R.R. Vreden Russian Scientific Research Institute of Traumatology and Orthopedics, St. Petersburg, RussiaView further author information
,
Denis A. BaranenkoInternational Research Centre “Biotechnologies of the Third Millennium”, ITMO University, St. Petersburg, Russia; View further author information
&
Alexey M. BelyaevScientific Laboratory of Cancer Chemoprevention and Oncopharmacology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia; View further author information
 show all
Pages 545-550 | Received 14 Mar 2017, Accepted 29 Aug 2017, Published online: 18 Sep 2017

References

  • Ferlay J, Soerjomataram I, Ervik M, et al. (2013). Estimated cancer incidence, mortality and prevalence worldwide in 2012. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr, accessed on day/month/year
  • Morgan RJ, Jr., Armstrong DK, Alvarez RD, et al. (2017). Ovarian cancer (Version 1.2016). Clinical practice guidelines in oncology [Internet]. NCCN. Available from: https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf
  • Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. (2014). Ovarian cancer. Lancet 384:1376–88.
  • Narod S. (2016). Can advanced-stage ovarian cancer be cured? Nat Rev Clin Oncol 13:255–61.
  • Polom K, Roviello G, Generali D, et al. (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer. Int J Hyperthermia 32:298–310.
  • Grosso G, Rossetti D, Coccolini F, et al. (2014). Intraperitoneal chemotherapy in advanced epithelial ovarian cancer: a survey. Arch Gynecol Obstet 290:425–34.
  • Lu Z, Wang J, Wientjes MG, Au JL-S. (2010). Intraperitoneal therapy for peritoneal cancer. Future Oncol 6:1625–41.
  • Hasovits C, Clarke S. (2012). Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics. Clin Pharmacokinet 51:203–24.
  • Gourley C, Walker JL, Mackay HJ. (2016). Update on intraperitoneal chemotherapy for the treatment of epithelial ovarian cancer. Am Soc Clin Oncol Educ Book 35:143–51.
  • Sakuragi N, Nakajima A, Nomura E, et al. (2000). Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma. Gynecol Oncol 79:420–3.
  • Gershanovich ML, Filov VA, Kotova DG, et al. (1998). Multicenter clinical trial of the antitumor drug dioxadet (phase II). Vopr Onkol 44:216–20.
  • Bespalov VG, Vyshinskaya EA, Vasil’eva IN, et al. (2017). Comparative study of antitumor efficiency of intraperitoneal and intravenous cytostatics in experimental rats with disseminated ovarian cancer. Bull Exp Biol Med 162:383–6.
  • Bespalov VG, Kireeva GS, Belyaeva OA, et al. (2016). Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model. J Surg Oncol 113:438–42.
  • Bespalov VG, Kireeva GS, Belyaeva OA, et al. (2016). Experimental study of antitumour activity and effects on leukocyte count of intraperitoneal administration and hyperthermic intraperitoneal chemoperfusion (HIPEC) with dioxadet in a rat model of ovarian cancer. J Chemother 28:203–9.
  • Bespalov VG, Vyshinskaya EA, Vasilieva IN, et al. (2015). Intraperitoneal chemotherapy – a method of improving treatment effectiveness in ovarian cancer. Vopr Onkol 61:634–41.
  • Bespalov VG, Kireeva GS, Belyaeva OA, et al. (2015). Intraoperative intraperitoneal chemoperfusion treatment with cisplatin and dioxadet on a model of peritoneal carcinomatosis in ovarian cancer: safety and efficacy evaluation. Vopr Onkol 61:647–52.
  • Wasserstein RL, Lazar NA. (2016). The ASA’s statement on p-values: context, process, and purpose. Am Stat 70:129–33.
  • Louis TA, Zeger SL. (2009). Effective communication of standard errors and confidence intervals. Biostatistics 10:1–2.
  • Hammer Ø, Harper DAT, Ryan PD. (2001). Paleontological statistics software package for education and data analysis. Palaeontol Electron 4:9–18.
  • Love JP, Selker R, Verhagen AJ, et al. (2015). Software to sharpen your stats. APS Obs 28:27–9.
  • Rouder JN, Speckman PL, Sun D, et al. (2009). Bayesian t tests for accepting and rejecting the null hypothesis. Psychon Bull Rev 16:225–37.
  • Faul F, Erdfelder E, Buchner A, Lang AG. (2009). Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41:1149–60.
  • LePrep – Probabilities of replication. (2017). Available from: http://lmrs.univ-rouen.fr/Persopage/Lecoutre/PAC.htm
  • R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. Available from: https://www.R-project.org [last accessed 26 Jul 2017].
  • Lemoine L, Sugarbaker P, Van der Speeten K. (2017). Drugs, doses, and durations of intraperitoneal chemotherapy: standardizing HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma. Int J Hyperth 33:582–92.
  • Jaaback K, Johnson N, Lawrie T, (2016). Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev 1:CD005340.
  • Cowan RA, O’Cearbhaill RE, Zivanovic O, Chi DS. (2017). Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer. Int J Hyperth 33:548–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.